Company intelligence / Profile preview

Baheal Medical

Qingdao, Shandong, Chinabaheal.cn ↗

Ownership: Private
Development stage: Other

Overview

Baheal Medical has successfully launched a variety of innovative products with proprietary intellectual property rights. Its portfolio includes modern TCMs, extended-release chemical medicines, OTC/general health products, OTX/prescription medicines, oncology drugs, and high-end medical devices. Key commercialized examples include Fuzheng Huayu Tablet/Capsule for hepatitis B-related liver fibrosis and Nida® metformin hydrochloride sustained-release tablets for type 2 diabetes. Clinical results are not detailed publicly.

Therapeutic areas: Metabolic DisordersGastroenterologyEndocrinology
Modalities: Small moleculeTraditional Chinese medicine (TCM)Extended release oral solid dosage (OSD) formulationsChemical medicine
Industry: Biotech

Beyond the preview

Go deeper on Baheal Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baheal Medical.

Explore the full profile